Life in the dark, frigid areas of the South China Sea isn’t exactly a walk in the park for microbes. To thrive, they’ve had to become incredibly competitive and resilient. Interestingly, some of these tiny organisms whip up chemical concoctions to defend themselves against threats, and researchers have recently stumbled upon one such weapon that might aid humans in combating cancer.
A fascinating study by scientists from the Chinese Academy of Sciences has unveiled EPS3.9, an elongated sugar produced by Spongiibacter nanhainus and its relatives. Initial tests revealed that this compound not only stalled tumor progression in lab-grown and mouse liver cancer models, but it also triggered strong immune responses, empowering the immune system to locate and combat cancer cells.
Setting Off an Alarm Within Tumors
Way back in 2024, researchers were investigating these microbes due to their inhibitory effects on certain agricultural fungi and dangerous bacteria, including some well-known drug-resistant ones. Recently, their focus shifted towards cancer, and they uncovered You won’t believe how effective EPS3.9 is against cancer!
This natural compound sets off a very cool process called pyroptosis, a wild and fiery type of programmed cell death where cells swell, explode, and spit out inflammatory chatter to summon immune cells to the scene. This is pretty different from apoptosis, the quieter form of cell death essential for healthy development. Tellingly, cancer cells often avoid normally orderly apoptosis to multiply unchecked, but pyroptosis disrupts this sneaky tactic.
This explosive way of eliminating tumor cells is like raising a red flag to the immune system, something that’s crucial since cancer cells typically have strategies to evade detection. By causing such a ruckus, EPS3.9 could launch a full-fledged immune response!
“Our findings not only lay the groundwork for better-carb based drugs but also underscore the benefits of tapping into marine microbial resources,” stated Chaomin Sun, PhD, one of the leading researchers from the Chinese Academy of Sciences.
Exploring Cancer Treatment from the Sea
Currently, EPS3.9 has shown impressive results in lab studies and among mice. When it was tested against human leukemia cells, it led to significant cell death. In mice with liver tumors, the compound notably shrank tumors and sparked anti-tumor immune responses.
Of course, there’s still a long road ahead before we can deem this as a safe and effective treatment for humans, but the potential is undeniably exciting!
Modern cancer treatments increasingly lean on the immune system for support. Treatments like checkpoint inhibitors and CAR-T cells have already changed the game for many patients. With EPS3.9, there’s a fresh strategy in town—actively destroying cancer cells in ways that demand the attention of the immune system! Since cancer cells usually slip through the immune radar, EPS3.9 disrupts this stealth mode, sounding the alarm for attacks.
Interestingly, microbes from the sea, particularly Spongiibacter, haven’t been fully exploited yet. The strangest life forms have labs buzzing with excitement, as these organisms thrive in extreme settings and develop unique biochemical properties. Over the years, scientists have discovered new antibiotics and antiviral substances from ocean life, and the emergence of EPS3.9 only adds to this impressive list.
If this compound proves both safe and effective in humans, we could see the dawn of a new type of carbohydrate-based approach to cancer treatment—one that doesn’t only annihilate tumors but also boosts our body’s defenses to keep battling ongoing issues. For now, this little microorganism from the ocean’s shadows may have uncovered a fascinating new avenue for tackling cancer.
Journal Reference: Ge Liu, Yeqi Shan, Chaomin Sun. A Novel Exopolysaccharide, Highly Prevalent in Marine Spongiibacter, Triggers Pyroptosis to Exhibit Potent Anticancer Effects. The FASEB Journal, 2025; 39 (14) DOI: 10.1096/fj.202500412R
This story originally appeared on ZME Science. Want to get smarter every day? Subscribe to our newsletter for the latest in science news.
